Back to News
Market Impact: 0.5

Seeing Machines CEO on accelerated royalties & profit path

Technology & InnovationAutomotive & EVCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsProduct LaunchesManagement & Governance
Seeing Machines CEO on accelerated royalties & profit path

Seeing Machines has negotiated and recognised this month a discounted lump-sum payment representing the full value of expected automotive royalties (discounted over five years), which management says will be booked as revenue and flow straight to profit and cash. The company achieved a cash-flow breakeven run rate by end-December, with December the first cash-flow positive and profitable month, and management is highly confident the second half (Q3 and Q4) will be profitable even without the accelerated royalty. At CES the company demonstrated 3D interior perception mapping with partner Valeo and intoxication-detection technology, underlining opportunities in software-defined vehicles, robotics and autonomous mobility that support its revenue and profit outlook.

Analysis

Market structure: The accelerated five-year discounted royalty payment materially improves Seeing Machines' (AIM:SEE / OTC:SEEMF) cash runway and immediately reduces insolvency/default tail risk; direct winners are SEE, its tier‑1 integration partners (e.g., Valeo VLE.PA) and software-defined-vehicle integrators. Losers include legacy, hardware‑only cabin sensor vendors and any small suppliers competing on price rather than integrated software; expect SEE to gain short‑term pricing power in OEM negotiations if it converts cash into accelerated deployment and certification support. Risk assessment: Key tail risks are customer concentration (four guaranteed programs), one‑off nature of lump sum revenues, and privacy/regulatory pushback on biometric/intoxication systems; a single customer cancellation would erode >20–30% of forward revenue visibility within 12 months. Timewise, immediate sentiment uplift (days–weeks) is likely; true business re‑rating requires demonstrated production ramps in 3–9 months and sustained recurring royalties over 12–24 months. Hidden dependency: SEE’s valuation now hinges on contract enforceability and OEM certification timelines, not just technology. Trade implications: Favor a tactical long in SEE sized to capture rerating (see decisions below); hedge execution risk via puts or a short in Smart Eye (STO:SEYE) as a relative play. Expect option IV compression within 1–3 weeks post‑release; use spreads to finance upside exposure. Rotate modest capital from legacy Tier‑1 hardware names (e.g., Continental CON.DE, -1–2% weight) into ADAS/software suppliers (Valeo VLE.PA, Aptiv APTV) over 1–3 months. Contrarian angles: Consensus may underappreciate that the lump‑sum is non‑recurring and could set a precedent for customers to seek similar settlements; downside is underwritten if SEE cannot convert CES PoCs into multi‑OEM production in 6–12 months. Conversely, CES demos (3D interior mapping, intoxication detection) create optionality that could deliver >2x upside if SEE lands 2–3 new OEM design wins within 12 months — a scenario markets often underprice for small-cap tech winners.